118 related articles for article (PubMed ID: 29469718)
21. Eccrine squamous syringometaplasia associated with vemurafenib therapy.
Story SG; Beschloss JK; Dolan CK; Thomas BC
J Am Acad Dermatol; 2012 Nov; 67(5):e208-10. PubMed ID: 23062917
[No Abstract] [Full Text] [Related]
22. Syringometaplasia: variants and underlying mechanisms.
Abbas O; Bhawan J
Int J Dermatol; 2016 Feb; 55(2):142-8. PubMed ID: 26460811
[TBL] [Abstract][Full Text] [Related]
23. Preliminary results of stem cell mobilization in chronic myeloid leukemia with a moderate intensity chemotherapy regimen and G-CSF or G-CSF plus IL-3.
Aulitzky WE; Neubauer A; Kolbe K; Schneller F; Busemann C; Schleiermacher E; Peschel C; Siegert W; Huber C; Huhn D
Bone Marrow Transplant; 1996 May; 17 Suppl 3():S67-9. PubMed ID: 8769707
[TBL] [Abstract][Full Text] [Related]
24. Eccrine squamous syringometaplasia of underlying syringoma associated with Tegafur/Gimeracil/Oteracil (TS-1).
Kim J; Kim SH; Lee MG; Chung KY; Kim DS
Acta Derm Venereol; 2015 Nov; 95(8):999-1000. PubMed ID: 25766447
[No Abstract] [Full Text] [Related]
25. [Eccrine hidradenitis. Case report and review of the literature].
Okcu A; Soyer HP; Kaddu S; Lackner H; Aberer E
Hautarzt; 1997 Oct; 48(10):743-8. PubMed ID: 9441168
[TBL] [Abstract][Full Text] [Related]
26. Eccrine squamous syringometaplasia in chemotherapy-induced acral erythema.
Rongioletti F; Rebora A
J Am Acad Dermatol; 1992 Feb; 26(2 Pt 1):284. PubMed ID: 1552086
[No Abstract] [Full Text] [Related]
27. Imatinib-induced eccrine squamous syringometaplasia.
Van de Voorde K; De Raeve H; Van Regenmortel N; Lambert J
J Am Acad Dermatol; 2006 Aug; 55(2 Suppl):S58-9. PubMed ID: 16843129
[No Abstract] [Full Text] [Related]
28. Syringosquamous metaplasia. A distinctive eruption in patients receiving chemotherapy.
Bhawan J; Malhotra R
Am J Dermatopathol; 1990 Feb; 12(1):1-6. PubMed ID: 2316809
[TBL] [Abstract][Full Text] [Related]
29. Neutrophilic eccrine hidradenitis.
Vion B; Alvero H
Dermatologica; 1991; 183(1):70-2. PubMed ID: 1769425
[TBL] [Abstract][Full Text] [Related]
30. Donor cell-derived acute myeloid leukemia developing 14 months after matched unrelated bone marrow transplantation for chronic myeloid leukemia.
Hambach L; Eder M; Dammann E; Battmer K; Stucki A; Heil G; Ganser A; Hertenstein B
Bone Marrow Transplant; 2001 Oct; 28(7):705-7. PubMed ID: 11704795
[TBL] [Abstract][Full Text] [Related]
31. Eccrine squamous syringometaplasia secondary to cutaneous extravasation of docetaxel: report of three cases.
Gallo E; Llamas-Velasco M; Navarro R; Fraga J; García-Diez A
J Cutan Pathol; 2013 Mar; 40(3):326-9. PubMed ID: 23170995
[TBL] [Abstract][Full Text] [Related]
32. Coexistence of eccrine squamous syringometaplasia and graft-versus-host disease in a patient with secondary myelodysplastic syndrome.
Carrascosa R; Concha MJ; Sánchez-Pérez J; Aragües M; Fraga J
Acta Derm Venereol; 2014 Sep; 94(5):599-600. PubMed ID: 24473864
[No Abstract] [Full Text] [Related]
33. Chemotherapy-related bilateral dermatitis associated with eccrine squamous syringometaplasia: reappraisal of epidemiological, clinical, and pathological features.
Martorell-Calatayud A; Sanmartín O; Botella-Estrada R; Balmer NN; Serra-Guillén C; Gomez-Moyano E; Traves-Zapata V; Requena C; Nagore E; Llombart-Cussac B; Guillen-Barona C
J Am Acad Dermatol; 2011 Jun; 64(6):1092-103. PubMed ID: 21489654
[TBL] [Abstract][Full Text] [Related]
34. Neutrophilic eccrine hidradenitis in acute myelomonocytic leukemia.
Katsanis E; Luke KH; Hsu E; Carpenter BF; Mantynen PR
Am J Pediatr Hematol Oncol; 1987; 9(3):204-8. PubMed ID: 3479026
[TBL] [Abstract][Full Text] [Related]
35. Eccrine squamous syringometaplasia in the skin of children after burns.
Sommer B; Hagedorn M; Wood F; Heenan P
J Cutan Pathol; 1998 Jan; 25(1):56-8. PubMed ID: 9508345
[TBL] [Abstract][Full Text] [Related]
36. Olanzapine-induced eccrine squamous syringometaplasia.
Molina-Ruiz AM; Molina-Ruiz RM; Zulueta T; Barabash R; Requena L
Am J Dermatopathol; 2012 Jun; 34(4):434-7. PubMed ID: 22257902
[TBL] [Abstract][Full Text] [Related]
37. Toxic erythema with eccrine squamous syringometaplasia induced by nanoparticle albumin-bound paclitaxel.
Fujii M; Takahashi I; Honma M; Ishida-Yamamoto A
J Dermatol; 2015 Nov; 42(11):1134-5. PubMed ID: 26299585
[No Abstract] [Full Text] [Related]
38. Gene expression profiles of two accelerations in a CML patient.
Fiser K; Klamová H; Moravcová J
Leuk Res; 2006 Jun; 30(6):751-3. PubMed ID: 16289682
[No Abstract] [Full Text] [Related]
39. Fludarabine, cytarabine, G-CSF and idarubicin (FLAG-IDA) for the treatment of relapsed or poor risk childhood acute leukemia.
Yalman N; Sarper N; Devecioğlu O; Anak S; Eryilmaz E; Can M; Yenilmez H; Ağaoğlu L; Gedikoğlu G
Turk J Pediatr; 2000; 42(3):198-204. PubMed ID: 11105617
[TBL] [Abstract][Full Text] [Related]
40. The effect of cyclosporin A used alone and in combination with either 2-chlorodeoxyadenosine or fludarabine on normal and chronic myelogenous leukemia progenitors in vitro.
Korycka A; Robak T
Arch Immunol Ther Exp (Warsz); 2003; 51(1):61-7. PubMed ID: 12691305
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
